Explainer
Landmark Trial: 10-Minute Digital Program Significantly Reduces Depression Symptoms
4 sources · 35d ago
Explainer
FDA Clears First Ibogaine Derivative Trial for Alcoholism, Expands Psychedelic Priority Vouchers
2 sources · 36d ago
Explainer
The Science Behind the Surgeon General's Push for Social Media Warning Labels
6 sources · 40d ago
More in Mental Health
Research BriefAdolescent Health
Massive Study Links Teen Cannabis Use to Double the Risk of Psychotic and Bipolar Disorders
Medical Consensus 45%Public Health Advocates 35%Science Communicators 20%
7 sources · 40d ago
ExplainerNeuromodulation
Implanted Vagus Nerve Stimulator Provides Durable, Two-Year Relief for Severe Depression
Clinical Researchers 40%Patient Advocates 35%Methodologists & Skeptics 25%
6 sources · 44d ago
Research BriefYouth Mental Health
National Survey Finds Significant Drop in Adolescent Depression and Suicidal Thoughts for First Time in Years
Public Health Officials 40%Clinical Psychiatrists 35%Local Government Advocates 25%
6 sources · 45d ago
ExplainerPsychiatric Medicine
FDA Clears First New-Mechanism Schizophrenia Drug in 30 Years
Psychiatric Researchers 44%Clinical Practitioners 33%Patient Advocates & Skeptics 22%
6 sources · 45d ago
ExplainerADHD Treatments
FDA Nears Approval for Centanafadine, a First-in-Class, Low-Abuse Potential ADHD Drug
Clinical Prescribers 40%Patient Advocates 35%Regulatory Specialists 25%
3 sources · 51d ago
Psychiatric GeneticsEvidence Pack
Landmark Genetic Study Finds Schizophrenia and Bipolar Disorder Share 70% of Underlying Risk
Genomic Researchers 40%Clinical Psychiatrists 35%Diagnostic Reformers 25%
4 sources · 53d ago









